Brain Monitoring Market Size - By Product Type (Device [CT, MRI, EMG, TCD], Accessories [Electrode]), Modality (Fixed, Portable, Wearable), Procedure (Invasive, Non-invasive), Application, End-use (Hospital, Diagnostic Center) – Global Forecast, 2024 – 2032

Brain Monitoring Market Size - By Product Type (Device [CT, MRI, EMG, TCD], Accessories [Electrode]), Modality (Fixed, Portable, Wearable), Procedure (Invasive, Non-invasive), Application, End-use (Hospital, Diagnostic Center) – Global Forecast, 2024 – 2032

Brain Monitoring Market Size

Brain Monitoring Market was valued at around USD 4.7 billion in 2023 and is estimated to reach over USD 8.2 billion by 2032. Brain monitoring refers to the process of observing and recording the physiological and electrical activity of the brain to assess its function and health. This monitoring is often conducted using various medical technologies and devices designed to measure and analyze different aspects of brain activity. Worldwide, the annual incidence of traumatic brain injury is estimated to range from 27 to 69 million. The aftermath of traumatic brain injury often leaves survivors coping with substantial disabilities, leading to a considerable socioeconomic burden.
 

Furthermore, there is a growing emphasis on developing and improving brain monitoring technologies for specific neurological disorders such as epilepsy, Parkinson’s disease, Alzheimer’s disease, and traumatic brain injury. Tailored solutions are being designed to address the unique monitoring needs of each condition. Thus, the aforementioned factors are projected to augment market growth.

Brain Monitoring Market Trends

Growing awareness and focus on brain health represent a significant societal shift towards recognizing the crucial role that brain well-being plays in overall health and quality of life. This emphasis on brain health encompasses various aspects, reflecting a holistic approach to maintaining and enhancing cognitive function, emotional well-being, and neurological resilience.
 

• The growing recognition of the interconnectedness between mental health and brain health has spurred conversations about destigmatizing mental health issues. There is an increased emphasis on understanding and addressing conditions such as depression, anxiety, and stress to support overall brain health.
   
• Ongoing research in neuroscience and neurology is contributing to a deeper understanding of brain health. Innovations in brain monitoring technologies, diagnostic tools, and therapeutic interventions are emerging, providing new avenues for early detection and personalized treatment of neurological conditions.
   

Brain Monitoring Market Analysis

The devices segment is poised for significant growth at a CAGR of over 6.5% through 2032. The segment is further bifurcated into magnetoencephalograph devices, electroencephalograph, cerebral oximeters, functional magnetic resonance imaging (fMRI), intracranial pressure monitoring devices, computerized tomography scanners (CT), positron emission tomography (PET), sleep monitoring devices, electromyography devices (EMG), transcranial doppler devices (TCD) and other devices.
 

• The integration of multiple monitoring modalities into a single device is becoming more common. Combining EEG, MRI systems, and other technologies allows for a comprehensive and holistic approach to brain monitoring, providing a more complete picture of brain function and health.
   
• Brain monitoring devices are increasingly offering real-time data analytics and connectivity features. This allows for instant data transmission to healthcare providers, enabling timely decision-making and intervention in critical situations.
   
• Thus, aforementioned factors will promote market growth during forecast period.
   

Based on modality, the fixed segment accounted for 55.5% share of the brain monitoring market in 2023 and is estimated to register significant growth up to 2032.
 

• The integration of advanced imaging technologies, such as high-resolution functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), into fixed brain monitoring devices provides clinicians with detailed insights into brain structure and function. This trend enhances diagnostic capabilities and contributes to a more comprehensive understanding of neurological conditions.
   
• Manufacturers are offering customizable configurations to meet the specific monitoring needs of different clinical specialties. This trend ensures that fixed devices can be tailored for applications such as neurosurgery, epilepsy monitoring, and research, providing versatility in clinical settings.
   

Based on type of procedure, the non-invasive segment was reached USD 3.9 billion in 2023.
 

• Non-invasive brain monitoring is increasingly integrated into mobile health platforms. This trend allows individuals to track and manage their brain health using smartphones or other portable devices, contributing to personalized and accessible healthcare.
   
• Non-invasive electroencephalography (EEG) technology has witnessed advancements, including the development of high-density EEG systems. These systems provide more detailed and accurate monitoring of brain activity without the need for invasive procedures.
   

The brain monitoring market by application is categorized into Parkinson’s disease, traumatic brain injury, epilepsy, dementia, sleep disorders, stroke, migraine, and other applications. The epilepsy segment captured for a revenue share of 19.7% in 2023.
 

• The development of seizure detection devices has been a notable trend. These devices, often worn by patients, use various sensors to detect and record seizures, providing valuable data for clinicians to assess seizure frequency, duration, and patterns.
   
• The integration of AI algorithms into epilepsy monitoring systems is enhancing the accuracy of seizure detection and analysis. AI can help differentiate between epileptic and non-epileptic events, improving diagnostic precision.
   

The brain monitoring market by end-use is categorized into hospitals, neurology centers, diagnostic centers, and other end-users. The hospitals segment size exceeded USD 1.5 billion in 2023.
 

• Hospitals are increasingly integrating advanced brain monitoring technologies into their diagnostic and treatment protocols. This includes the use of devices such as EEG, fMRI, and other neuroimaging techniques to aid in the assessment of neurological conditions.
   
• The establishment and expansion of neurocritical care units within hospitals are notable trends. These specialized units focus on the management of critically ill patients with neurological conditions, utilizing advanced brain monitoring devices to provide intensive care and real-time monitoring.
   

North America brain monitoring market accounted for USD 2.1 billion revenue in 2023 and is predicted to witness substantial market growth during 2024 and 2032.
 

• Neurocritical care units in North American hospitals are gaining prominence. These specialized units focus on the critical care management of patients with severe neurological conditions, utilizing advanced monitoring techniques to optimize patient outcomes.
   
• The use of telemedicine and remote monitoring solutions has seen significant growth, driven in part by the COVID-19 pandemic. North American healthcare providers are increasingly leveraging these technologies for remote consultations, follow-up care, and continuous monitoring of patients with neurological disorders.
   
• North America is a hub for research and development in the healthcare sector, including brain monitoring. Ongoing research activities focus on refining existing technologies, developing innovative monitoring solutions, and exploring new applications in neuroscience.
   

Brain Monitoring Market Share

The brain monitoring industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Siemens Healthineers, GE Healthcare, Medtronic plc, among others have a notable presence in the market.
 

Brain Monitoring Market Companies

Some of the eminent market participants operating in the brain monitoring industry include

• BrainScope Company, Inc.
• Cadwell Industries, Inc.
• Compumedics Limited
• Edwards Lifesciences
• Elekta AB
• GE Healthcare
• Koninklijke Philips N.V.
• Medtronic plc
• Natus Medical Incorporated
• Siemens Healthineers AG
   

Brain Monitoring Industry News

• In December 2023, Siemens Healthineers launched the MAGNETOM Cima.X, a groundbreaking 3T MRI system, in Canada, following its Health Canada licensing. This release aimed to extend its market presence, strengthening Siemens Healthineers' competitive position in the Canadian market.
   
• In November 2023, Royal Philips launched its inaugural mobile MRI system, BlueSeal MR Mobile, featuring helium-free operations at RSNA23. This 1.5T fully sealed magnet prioritized patient-centric MRI services. The product launch helped Philips to extend accessible, sustainable, and helium-free MRI exams to diverse locations, stimulating the company's revenue.
   

This brain monitoring market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

Market, By Product Type

• Devices
  • Magnetoencephalograph devices
  • Electroencephalograph
  • Cerebral oximeters
  • Functional magnetic resonance imaging (fMRI)
  • Intracranial pressure monitoring devices
  • Computerized tomography scanners (CT)
  • Positron emission tomography (PET)
  • Sleep monitoring devices
  • Electromyography devices (EMG)
  • Transcranial doppler devices (TCD)
  • Other devices
• Accessories
  • Electrodes
  • Sensors
  • Caps
  • Cables
  • Paste or gel
  • Other accessories

Market, By Modality

• Fixed
• Portable
• Wearable

Market, By Type of Procedure

• Invasive
• Non-invasive

Market, By Application

• Parkinson’s disease
• Traumatic brain injury
• Epilepsy
• Dementia
• Sleep disorders
• Stroke
• Migraine
• Other applications

Market, By End-use

• Hospitals
• Neurology centers
• Diagnostic centers
• Other end-users

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa